Sanofi Invests $11M Into Needle-Free Injection System

Eternity Healthcare Inc.

, a medical device and diagnostic company with advanced technologies using the Needle-Free Injection system, announced today that its competitor company, Portal Instruments® Inc., has secured an $11 Million investment for their Needle-Free Injection System from Sanofi, this investment comes through their Sunrise initiative. "CAMBRIDGE, Mass. October 15, 2014 – Portal Instruments, Inc., a new dynamic, emerging leader in the development of innovative drug delivery systems, announced today that it has completed a landmark $11 million Series A financing led by Sanofi through its Sunrise initiative along with PBJ Capital (a Boston-based venture firm) and a major US medical device company." Dr. Salari, C.E.O. of Eternity Healthcare Inc. said: "With this new investment into the Needle-Free Injection Market, it shows that major pharmaceuticals and biotechnology companies are looking for alternative ways to administer their products, and appeal to the masses." He went on to state: "Using a Needle-Free Injection device can provide not only a pain free way to administer their products, but it is a more convenient way for patients to receive their medication." He concluded by saying: "Eternity Healthcare is one of the front runners in the Needle-Free Injection System Market and has on the market the Comfort-in™ Needle-Free Injection System. We currently have many products under development. These new products should capture the attention of other major pharmaceutical companies wishing to compete with Portal Instruments®."